Perbandingan Angka Kematian Terapi Antiviral Favipiravir dan Remdesivir pada Pasien COVID-19 Di RSUP Dr. Sardjito Yogyakarta
Antiviral treatment for SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) is still being studied for its effectivity. The antivirals in the July 3, 2021 edition of the COVID-19 management guidelines, namely favipiravir and remdesivir, are used for moderate, severe and critical degrees. The...
| 出版年: | Jurnal Manajemen dan Pelayanan Farmasi |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | インドネシア語 |
| 出版事項: |
Universitas Gadjah Mada
2023-01-01
|
| 主題: | |
| オンライン･アクセス: | https://jurnal.ugm.ac.id/jmpf/article/view/77288 |